pREBOA-PRO
Device Dqy
General payments
$498,010
Research payments
$1,473,428
Through program year 2025, $498,010 in general payments and $1,473,428 in research payments were reported against pREBOA-PRO (Dqy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $296,466 | 129 |
| 2025 | Research | $817,452 | 55 |
| 2024 | General | $201,544 | 82 |
| 2024 | Research | $516,137 | 49 |
| 2023 | Research | $139,839 | 12 |
Breakdown
The top 5 of 32 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
211 general · 116 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.